Callan Family Office LLC Purchases Shares of 2,964 Axon Enterprise, Inc $AXON

Callan Family Office LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, HoldingsChannel reports. The fund acquired 2,964 shares of the biotechnology company’s stock, valued at approximately $2,454,000.

Several other institutional investors have also recently made changes to their positions in the company. TCTC Holdings LLC grew its position in Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after acquiring an additional 33 shares in the last quarter. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the 1st quarter valued at about $31,000. Catalyst Capital Advisors LLC purchased a new position in shares of Axon Enterprise in the 1st quarter valued at about $32,000. Finally, Flaharty Asset Management LLC acquired a new position in Axon Enterprise in the 1st quarter worth about $33,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Axon Enterprise news, CAO Jennifer H. Mak sold 77 shares of the company’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares in the company, valued at $11,402,280. This represents a 0.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on AXON. JMP Securities reissued a “market outperform” rating and issued a $825.00 price objective on shares of Axon Enterprise in a report on Monday, September 29th. Raymond James Financial reissued an “outperform” rating and issued a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective on the stock in a report on Tuesday, August 5th. Finally, Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $703.03 on Friday. The company has a fifty day simple moving average of $755.57 and a 200-day simple moving average of $713.70. The firm has a market capitalization of $55.19 billion, a price-to-earnings ratio of 173.59, a PEG ratio of 27.30 and a beta of 1.41. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.